Evidence map›Paper›PMID 36922463›Full record

ArticleDermatology and therapy2023

Similarities and Differences in the Perception of Atopic Dermatitis Burden Between Patients, Caregivers, and Independent Physicians (AD-GAP Survey).

Amy S Paller, Stephan Weidinger, Korey Capozza, Andrew E Pink, Mark Tang, Xavier Guillaume, Amy Praestgaard, Marjorie Leclerc, Chien-Chia Chuang, Ryan B Thomas and 1 more

Open access · goldAbstract read
In one paragraph

Article in Dermatology and therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Amy S PallerNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
Stephan WeidingerUniversity Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Korey CapozzaGlobal Parents for Eczema Research, Santa Barbara, CA, USA.
Andrew E PinkSt John's Institute of Dermatology, Guy's & St. Thomas' Hospitals, London, UK.
Mark TangMount Alvernia Medical Centre, Singapore, Singapore.
Xavier GuillaumeCerner Enviza, Paris, France.
Amy PraestgaardSanofi, Cambridge, MA, USA.
Marjorie LeclercCerner Enviza, Paris, France.
Chien-Chia ChuangSanofi, Cambridge, MA, USA.
Ryan B ThomasRegeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
Randy PrescillaSanofi, Cambridge, MA, USA. Randy.Prescilla@sanofi.com.
Sanofi (United States) · USMount Elizabeth Hospital · SGNational Eczema Association · USNorthwestern University · USRegeneron (United States) · USSt Thomas' Hospital · GBUniversity Hospital Schleswig-Holstein · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAtopic dermatitis (AD)-a chronic inflammatory skin disease characterized by intense itching-can have a detrimental impact on quality of life (QoL). We report results of a quantitative assessment of pediatric patient, caregiver, and physician perceptions of AD burden in children and adolescents.

methodsPediatric patients (aged 6-11 [children] or 12-17 [adolescents] years) with moderate-to-severe AD, their caregivers, and independent physicians were recruited in 13 countries. Caregivers and their children/adolescents completed an online survey about the impact of AD on 16 key items of patient QoL. Physicians completed surveys on their patients aged 6-11 and 12-17 years. Best-worst scaling was used to rank the importance of the QoL items.

resultsOverall, 1447 children/adolescents with moderate-to-severe AD (aged 6-11 years: 701; 12-17 years: 746), 1447 caregivers, and 1092 physicians participated. Patients and caregivers in both age groups ranked disturbed sleep as the most important QoL item, followed by feeling ashamed because of AD. Independent physicians ranked feeling ashamed because of AD as the most important QoL item for both age groups, followed by disturbed sleep for those aged 6-11 years and being singled out for those aged 12-17 years. The relative importance of the 16 QoL items to patients was strongly aligned between patients in both age groups and their caregivers, but somewhat less so between patients and physicians. Between-country differences were more apparent in physician- versus patient-/caregiver-reported results.

conclusionThe most burdensome QoL items were impact of AD on sleep and feeling ashamed. Caregivers and physicians correctly identified the QoL items most burdensome to patients. However, patient and caregiver perceptions were generally more closely aligned than patient and physician perceptions. Between-country differences in perceptions (particularly for physicians) were observed, probably due to multifactorial reasons, necessitating further evaluation. Video Abstract (MP4 42,877 kb) INFOGRAPHIC.

Indexed as

Atopic dermatitisBest–worst scalingDupilumabQuality of life

Identifiers

PMID36922463
PMCPMC10060494
OpenAlexW4324324651

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.